These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 26001859

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Factors Associated With Successful Withdrawal of Biologic Agents in Children With Colchicine-Resistant Familial Mediterranean Fever.
    Taş Ö, Aydın F, Sezer M, Çelikel Acar B, Bahçeci O, Çakar N, Dumlupınar E, Özçakar ZB.
    J Clin Rheumatol; 2024 Oct 01; 30(7):257-263. PubMed ID: 39226611
    [Abstract] [Full Text] [Related]

  • 25. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA, Kilic L, Akdogan A, Kiraz S, Kalyoncu U, Karadag O, Ertenli I, Dogan I, Calguneri M.
    J Clin Rheumatol; 2011 Oct 01; 17(7):358-62. PubMed ID: 21946459
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, Shcherbina A, Hofer M, Hashkes PJ, Van der Hilst J, Hara R, Bujan-Rivas S, Constantin T, Gul A, Livneh A, Brogan P, Cattalini M, Obici L, Lheritier K, Speziale A, Junge G.
    N Engl J Med; 2018 May 17; 378(20):1908-1919. PubMed ID: 29768139
    [Abstract] [Full Text] [Related]

  • 28. Canakinumab as monotherapy for treatment of familial Mediterranean fever - first report in Central and Eastern Europe region.
    Jesenak M, Hrubiskova K, Kapustova L, Kostkova M, Banovcin P.
    Bratisl Lek Listy; 2018 May 17; 119(4):198-200. PubMed ID: 29663815
    [Abstract] [Full Text] [Related]

  • 29. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L, Marchetti F, Tommasini A, Ventura A.
    Eur J Pediatr; 2008 Jun 17; 167(6):695-6. PubMed ID: 17588171
    [Abstract] [Full Text] [Related]

  • 30. Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.
    Kisla Ekinci RM, Balci S, Dogruel D, Altintas DU, Yilmaz M.
    Paediatr Drugs; 2019 Oct 17; 21(5):389-395. PubMed ID: 31463794
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.
    Alpay N, Sumnu A, Calışkan Y, Yazıcı H, Türkmen A, Gül A.
    Rheumatol Int; 2012 Oct 17; 32(10):3277-9. PubMed ID: 20386914
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
    Erten S, Erten SF, Altunoglu A.
    Rheumatol Int; 2012 Apr 17; 32(4):1095-7. PubMed ID: 21431291
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A.
    Arthritis Rheumatol; 2017 Apr 17; 69(4):854-862. PubMed ID: 27860460
    [Abstract] [Full Text] [Related]

  • 38. The clinical role of anakinra in the armamentarium against familial Mediterranean fever.
    Parlar K, Ates MB, Egeli BH, Ugurlu S.
    Expert Rev Clin Immunol; 2024 May 17; 20(5):441-453. PubMed ID: 38133629
    [Abstract] [Full Text] [Related]

  • 39. Anakinra for colchicine refractory familial Mediterranean fever: a cohort of 44 patients.
    Marko L, Shemer A, Lidar M, Grossman C, Druyan A, Livneh A, Kivity S.
    Rheumatology (Oxford); 2021 Jun 18; 60(6):2878-2883. PubMed ID: 34144604
    [Abstract] [Full Text] [Related]

  • 40. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.
    Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, Cınar M, Yilmaz S, Onat AM, Kisacik B, Erden A, Balkarli A, Kucuksahin O, Oner SY, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarlıoglu M, Dogru A, Yildirim G, Oner FA, Tezcan ME, Pamuk ON, Onen F.
    Arthritis Care Res (Hoboken); 2018 Jul 18; 70(7):1090-1094. PubMed ID: 28992387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.